IT-Bentazon 480 DK

Primær information

  • Handelsnavn:
  • IT-Bentazon 480 DK Flydende middel
  • Lægemiddelform:
  • Flydende middel
  • Sammensætning:
  • 480 g/l bentazon
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • IT-Bentazon 480 DK Flydende middel
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 378-53
  • Sidste ændring:
  • 07-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

1-2-2018

Brexit, change of Reference Member State from UK to DK

Brexit, change of Reference Member State from UK to DK

The Danish Medicines Agency would like to inform marketing authorisation holders that we welcome being the Reference Member State (RMS) for MRP/DCP authorised medicines, should you request Denmark as the future RMS when the UK is leaving the EU.

Danish Medicines Agency

11-9-2017

 DKMA Update

DKMA Update

Our newsletter Danish Pharmacovigilance Update changes name to DKMA Update and will from now on contain information about medicinal products in general, patient safety and life science. DKMA Update is an electronic newsletter intended for anyone who work with medicines, either clinically or in the pharmaceutical industry or the retail industry, and people who would like to gain an insight into our work. The newsletter will continue to focus on the most recent safety updates, but will also focus on other...

Danish Medicines Agency

16-8-2017

 Testing the exchange of E2B files

Testing the exchange of E2B files

Testing the exchange of E2B ICSRs/SUSARs between the Danish Medicines Agency and companies/sponsors must be completed by Friday 29 September 2017. The reason is that our test environment will be reconfigured to tests with the EMA in connection with the preparations for the changed reporting process for ICSRs that will take effect on 22 November 2017. Tests with sponsors will be resumed after 22 November 2017 since the applicable reporting process for SUSARs will not be changed. Companies that want to s...

Danish Medicines Agency

3-7-2017

 New fees for medicinal products, pharmaceutical companies and clinical trials from 1 July 2017

New fees for medicinal products, pharmaceutical companies and clinical trials from 1 July 2017

On 1 July 2017, a new executive order on fees payable for medicinal products, pharmaceutical companies and clinical trials became effective. The new fees involve changes in a number of areas. Changes in relation to marketing authorisations and variations etc. In connection with applications for marketing authorisations and variations etc., the new executive order entails a number of changes to the size of fees and the way in which they are calculated. Changes will be made to:Applications for new marketi...

Danish Medicines Agency

23-5-2017

 The Danish Medicines Agency will be closed on 26 May

The Danish Medicines Agency will be closed on 26 May

The Danish Medicines Agency will be closed on 26 May, the day after Ascension Day. Compassionate use permits However, we process urgent applications for compassionate use permits (applications for dispensing of non-marketed medicines). Physicians, dentists or veterinarians can submit applications electronically by using a NemID employee signature or via fax to +45 44 88 91 17. Please mark the application URGENT. We will be taking questions about compassionate use permits on +45 44 88 95 36 or by mail to...

Danish Medicines Agency

3-2-2017

Update on Europharma DK

Update on Europharma DK

Europharma DK can now legally sell medicines repacked and released by Abacus Medicine.

Danish Medicines Agency

3-1-2017

Suspension of Europharma DK ApS’ authorisation to manufacture and distribute parallel imported medicinal products

Suspension of Europharma DK ApS’ authorisation to manufacture and distribute parallel imported medicinal products

Today, 3 January 2017, the Danish Medicines Agency suspended Europharma DK ApS’ authorisation number 30308 issued on 23 March 2015 for the manufacturing and import of medicinal products and intermediate products (GMP authorisation).

Danish Medicines Agency

3-2-2016

Summary of product characteristics and package leaflet to be updated after the establishment of DKMA

Summary of product characteristics and package leaflet to be updated after the establishment of DKMA

Following the establishment of the Danish Medicines Agency (DKMA) on 8 October 2015, the section on the reporting of side effects must be updated in the summary of product characteristics (section 4.8) and the package leaflet (section 4) so that it says the Danish Medicines Agency and dkma@dkma.dk in the section about reporting of side effects.

Danish Medicines Agency

4-1-2016

The Danish Medicines Agency has a new website

The Danish Medicines Agency has a new website

Today, the Danish Medicines Agency launched its new website – laegemiddelstyrelsen.dk/en – where you can read about and subscribe to news about licensing and supervision of medicines, side effects, reimbursement, pharmacies and medical devices.

Danish Medicines Agency

11-3-2010

Strengthened warning against Alscreme 'Creme  nr. 2' from www.eminescu.dk

Strengthened warning against Alscreme 'Creme nr. 2' from www.eminescu.dk

On 12 February 2010, the Danish Medicines Agency warned strongly against using the product Alscreme 'Creme nr. 2' sold via www.eminescu.dk, as the product is an unlicensed medicinal product that contains active substance clobetasol.

Danish Medicines Agency

16-2-2010

Warning against ‘Alscreme Creme nr. 2’ from www.eminescu.dk

Warning against ‘Alscreme Creme nr. 2’ from www.eminescu.dk

The Danish Medicines Agency warns strongly against use of the product 'Alscreme Creme nr. 2' sold via www.eminescu.dk, as the product is an unauthorised medicinal product containing the active substance clobetasol.

Danish Medicines Agency

19-10-2007

Warning: Illegal sibutramine-containing weight-loss products sold on the internet

Warning: Illegal sibutramine-containing weight-loss products sold on the internet

The illegal Chinese weight-loss products LiDa (DaiDaiHuaJioaNang) and Miaozi are being sold on the internet, e.g. at the Danish language version of www.hurtigslank.dk (www.fastslim.dk).

Danish Medicines Agency

20-6-2017

Xagrid (Shire Pharmaceutical Contracts Ltd)

Xagrid (Shire Pharmaceutical Contracts Ltd)

Xagrid (Active substance: anagrelide) - PSUSA - Modification - Commission Decision (2017)4319 of Tue, 20 Jun 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/480/PSUSA/208/201609

Europe -DG Health and Food Safety